Weekly curated updates on drug launches, global approvals, and pharma R&D developments

December 13, 2025

1) FDA Approves DAYBUE® STIX for Rett Syndrome (12 Dec 2025) What’s new: The U.S. FDA has given the green l...

Read Full Story

Reach verified pharma buyers, suppliers & decision makers worldwide.

Connect with partners, startups & ventures driving the future of pharma.

Advertise on the fastest-growing B2B pharma marketplace.

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.

PharmaTradz is your trusted B2B pharma platform connecting professionals across the industry.

Know More

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.